{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:40:07Z","timestamp":1776699607184,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.clinbiochem.2010.12.003","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T04:33:33Z","timestamp":1292474013000},"page":"300-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Decreased small dense LDL levels in Gilbert's syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Serkan","family":"Tapan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Karadurmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teoman","family":"Dogru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemal Nuri","family":"Ercin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilker","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumhur","family":"Bilgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Kemal","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.10209","article-title":"Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil","volume":"108","author":"Fertrin","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0010","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1055\/s-2008-1068222","article-title":"Prevalence of Gilbert's syndrome in Germany","volume":"112","author":"Sieg","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1258\/000456306778520034","article-title":"Gilbert's syndrome: an overview for clinical biochemists","volume":"43","author":"Hirschfield","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"Vitek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1373\/49.7.1039","article-title":"Bilirubin concentration, UGT1A1*28 polymorphism, and coronary artery disease","volume":"49","author":"Schwertner","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies","volume":"228","author":"Novotny","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1079\/PNS19990022","article-title":"Lipoprotein atherogenicity: an overview of current mechanisms","volume":"58","author":"Griffin","year":"1999","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(94)92346-9","article-title":"The oxidation hypothesis of atherosclerosis","volume":"344","author":"Witztum","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2004.10.037","article-title":"Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase","volume":"179","author":"Yoshida","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijcard.2003.10.035","article-title":"Insulin resistance increases circulating malondialdehyde-modified LDL and impairs endothelial function in healthy young men","volume":"97","author":"Mizuno","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0060","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","article-title":"Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes","volume":"103","author":"Ehara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0070","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1194\/jlr.D300007-JLR200","article-title":"A novel and simple method for quantification of small dense LDL","volume":"44","author":"Hirano","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","article-title":"Association of low serum concentration of bilirubin with increased risk of coronary artery disease","volume":"40","author":"Schwertner","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.ATV.16.2.250","article-title":"Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease","volume":"16","author":"Hopkins","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Qu\u00e9bec Cardiovascular Study","volume":"25","author":"St-Pierre","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9343(00)00700-2","article-title":"Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins","volume":"110","author":"Tribble","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0095","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0100","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","article-title":"Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation","volume":"269","author":"Neuzil","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2760(95)00125-V","article-title":"Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin","volume":"1259","author":"Hulea","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0024-3205(94)90140-6","article-title":"Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox","volume":"54","author":"Wu","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","article-title":"Antioxidation human low density lipoprotein by unconjugated conjugated bilirubins","volume":"51","author":"Wu","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1746.2006.04564.x","article-title":"Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome","volume":"22","author":"Vitek","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0125","first-page":"387","article-title":"Decreased levels of advanced glycation end-products in patients with Gilbert syndrome","volume":"51","author":"Kalousova","year":"2005","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0130","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.298.12.1398-b","article-title":"Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes","volume":"298","author":"Inoguchi","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","article-title":"Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection","volume":"199","author":"Bulmer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0140","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1440-1746.2008.05388.x","article-title":"Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome","volume":"23","author":"Yesilova","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0145","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0150","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","article-title":"Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?","volume":"110","author":"Shoenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0155","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.ATV.0000157979.51673.2c","article-title":"C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein","volume":"25","author":"Van Tits","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0160","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0165","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1021\/bi050497v","article-title":"Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages","volume":"44","author":"Stewart","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.190.4.585","article-title":"The major receptor for C-reactive protein on leukocytes is fcgamma receptor II","volume":"190","author":"Bharadwaj","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.atherosclerosis.2005.05.011","article-title":"Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima\u2013media thickness in both men and women","volume":"184","author":"Erdogan","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2010.12.003_bb0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.clinbiochem.2009.02.005","article-title":"Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?","volume":"42","author":"Tapan","year":"2009","journal-title":"Clin Biochem"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912010005102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912010005102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:33:45Z","timestamp":1757864025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912010005102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0009912010005102"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.12.003","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased small dense LDL levels in Gilbert's syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}